Skip to content

Tetraone System for Epics Xl Flow Cytometry Systems with Cyto-Stat Tetrachrome CD45-Fitc/CD4-RD1/CD8-Ecd/CD3-PC5 Monocla

by Coulter Corp.

510(k) K990172

Active European Union and United States

CE IVDR CE IVDD 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None ongoing

1 closed

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK990172 Date13 Apr 1999ClearedStatusActive
European UnionCE/IVDR EUDAMED Number— Date—StatusActive
European UnionCE/IVDD EUDAMED Number— Date—StatusActive

Recalls

1 recall · FDA

    • Terminated Z-0472-2019 FDA Class I initiated 12 Jan 2018

    A manufacturing defect on the amplifier board of the Flow Cytometers my cause signal loss and/or signal drifting resulting in absence of data or a population shift in the data plots. This can impact patient results for any application.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR, CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA Product Code
GKZ
Device Class
Class II
Regulation
21 CFR Part 864.5220
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The TetraOne System for EPICS XL Flow Cytometry is a counter, differential cell device designed for hematological analysis. It employs flow cytometry to enumerate and differentiate white blood cell subsets, including CD45, CD4, CD8, and CD3 markers, using fluorescently labeled monoclonal antibodies (Cyto-Stat Tetrachrome). This system facilitates precise immunophenotyping for clinical diagnostics, particularly in assessing immune cell populations for conditions such as HIV, leukemia, and other hematologic disorders.

The device is intended for use in clinical laboratories and is supplied as a reusable flow cytometry platform paired with single-use reagent kits. Authorized under FDA 510(k) clearance (K990172) and compliant with In Vitro Diagnostic Device Regulations (IVDD/IVDR), it operates within Class II (risk classification) and is classified under regulation number 864.5220. Storage and handling follow standard laboratory protocols for flow cytometry instruments, with reagent kits requiring refrigeration as specified by the manufacturer.

Other devices from Coulter Corp.

See all devices from Coulter Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical conditions is the TetraOne System primarily used to diagnose or monitor, and how does it help in those cases?

    The TetraOne System is designed for precise immunophenotyping of immune cell populations, particularly focusing on CD45, CD4, CD8, and CD3 markers. It is primarily used in clinical diagnostics to assess conditions like HIV (by monitoring CD4+ T-cell counts), leukemia, and other hematologic disorders. By enumerating and differentiating white blood cell subsets via flow cytometry, it provides critical data for immune system evaluation, aiding in disease monitoring, treatment planning, and patient management.

  • Is the TetraOne System reusable, and if so, what about the reagents used with it?

    Yes, the TetraOne System itself is a reusable flow cytometry platform. However, the reagents—specifically the Cyto-Stat Tetrachrome CD45-FITC/CD4-RD1/CD8-ECD/CD3-PC5 monoclonal antibodies—are supplied as single-use kits. This design ensures consistency and sterility for each test while allowing the core instrument to be used repeatedly across multiple analyses.

  • How should the reagent kits for the TetraOne System be stored, and why is this important?

    The reagent kits for the TetraOne System require refrigeration as specified by the manufacturer. Proper refrigeration is critical to maintain the stability and efficacy of the fluorescently labeled monoclonal antibodies, ensuring accurate and reliable immunophenotyping results. Failure to follow storage guidelines could compromise reagent integrity and lead to inaccurate diagnostic outcomes.

  • What regulatory pathways has the TetraOne System undergone, and what does this mean for its use in clinical settings?

    The TetraOne System has undergone FDA 510(k) clearance (K990172) and complies with In Vitro Diagnostic Device Regulations (IVDD/IVDR). This means it has been evaluated for safety and performance by regulatory authorities and is classified as a Class II medical device under regulation number 864.5220. Clinically, this indicates it meets established standards for use in hematological analysis, providing assurance of its reliability for diagnosing and monitoring immune-related conditions in accredited laboratories.